• the TINN (Treat Infections in Neonates) study aims to find more information about the antibiotic ciprofloxacin including safety, most effective dose and other factors that may influence the way babies respond to the drug.
We hope that in the future, next generation DNA sequencing will be able to provide a diagnosis for more patients with genetic disorders.
It would offer breast augmentation, tummy tucks, chemical peels, nose reshaping, liposuction, eyelid reduction and botox.
Kathryn Thomson the chief executive said "the austerity measures mean we have to be more innovative and creative and I do believe there can be a healthy partnership between the NHS and private medicine.
We are fundamentally an NHS trust but we've got to be creative and find ways to keep what I think is an absolutely fantastic hospital viable and affordable and to maintain the standard I believe patients should expect when they visit us.
[3] " The Trust runs the Hewitt Fertility Centre, in Liverpool and Knutsford, which carries out 2,500 cycles of in-vitro fertilisation for public and private patients a year and employs 60 staff.
[4] In March 2015 the trust forecast a deficit of £2.1 million and saw no way of reducing that in future, because, Kathryn Thomson, the Chief Executive said, " the way the payment system in the NHS works does not provide our maternity services with the level of income that is required to afford the workforce."
[5] New arrangements by the NHS Litigation Authority mean that the trust has to pay for claims related to cases dating back to 2001.